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Abstract
Introduction: An expanded hexanucleotide repeat in the C9ORF72 gene has recently been identified as an
important cause of frontotemporal dementia and motor neuron disease; however, the phenotypic spectrum of this
entity and its pathophysiologic basis have yet to be fully defined. Psychiatric features may be early and prominent,
although a putative cortico-thalamo-cerebellar network has been implicated in the pathogenesis of the clinical
phenotype. Differentiation of self from others is a core cognitive operation that could potentially link network
disintegration with neuropsychiatric symptoms in C9ORF72-associated frontotemporal dementia.
Methods: We undertook a detailed behavioral analysis of self-other attribution in a 67-year-old male patient with
behavioral variant frontotemporal dementia (bvFTD) due to the C9ORF72 expansion by using a novel paradigm
requiring differentiation of the effects of self- and non-self-generated actions. The patient’s performance was
assessed in relation to two older male patients with bvFTD not attributable to the C9ORF72 expansion and four
healthy older male subjects.
Results: Compared with the healthy control group, the patient with the C9OFR72 mutation showed a deficit of
self-other differentiation that was disproportionate to his otherwise relatively indolent clinical phenotype. The
performance of the other patients with bvFTD was similar to that of healthy subjects.
Conclusion: We propose that impaired self-other differentiation is a candidate mechanism for neuropsychiatric
decline in association with the C9ORF72 expansion. We offer this preliminary observation as a stimulus to further
work.
Introduction
An expanded hexanucleotide repeat in the C9ORF72 gene
has recently been identified as an important cause of fron-
totemporal dementia and motor neuron disease [1-3];
however, the phenotypic spectrum of this entity and its
pathophysiologic basis have yet to be fully defined. Psy-
chiatric manifestations including delusions, hallucinations,
and severe anxiety disorders have been identified as fre-
quent and prominent and may be presenting features
[1,3,4]. Although detailed neuroanatomic-phenotypic cor-
relation has yet to be undertaken in the C9ORF72 muta-
tion spectrum, a culprit cortico-thalamo-cerebellar
network has been identified as a potential substrate for
certain clinical features, in particular, for neuropsychiatric
symptoms [1]. Differentiation of self from others is a core
cognitive operation that could potentially link network dis-
integration with neuropsychiatric symptoms in C9ORF72-
associated frontotemporal dementia. Disordered self-other
differentiation has been implicated in the pathogenesis of
various psychiatric conditions, including schizophrenia,
out-of-body autoscopic experiences, anxiety, and depres-
sion [5-8]. Neuroimaging evidence in the healthy brain
suggests that the cerebellum is a key component of distrib-
uted cortico-subcortical circuitry that represents and cali-
brates the effects of actions generated by oneself and
others [5,9].
We recently had the opportunity to investigate this issue
in a patient, NT, with the C9ORF72 expansion, who exhib-
ited an indolent phenotype of behavioral variant fronto-
temporal dementia (bvFTD) with relative preservation of
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many cognitive abilities. We designed a novel behavioral
paradigm specifically to assess NT’s ability to distinguish
between the effects of self- and non-self-generated actions.
We assessed NT in relation to a group of healthy older
male control subjects and two older male patients (DC1





NT is a 67-year-old right-handed male retired informa-
tion technology consultant with a postgraduate degree
qualification. He presented with an insidious decline in
personality and behavior extending over some 20 years.
His increasing impassivity, impulsivity, and distractibility
had led to his retirement from work. His wife reported
that he was less gregarious and less empathic, more
obsessional about money, and showed an increased pre-
ference for sweet foods. He made tactless remarks to
strangers and had only limited insight into his difficulties.
No concern had been expressed about his episodic mem-
ory or route-finding abilities, and his language, though
somewhat tangential, remained articulate. No history
suggested delusions, hallucinations, or other perceptual
disturbance. A family history existed of behavioral
decline in NT’s mother from age 50, and dementia with
parkinsonism in a maternal uncle. NT’s general neurolo-
gic examination was unremarkable; in particular, no fea-
tures of motor neuron disease were found. Longitudinal
neuropsychological assessment over a 9-year interval
demonstrated a largely stable profile with superior per-
formance in most cognitive domains and only a mild
relative weakness of aspects of executive function; NT’s
general neuropsychological data at the time of the experi-
mental assessment are summarized in Table 1. NT ful-
filled current consensus criteria for a syndromic
diagnosis of bvFTD [10].
Serial registered T1-weighted volumetric brain MRI
demonstrated progressive, diffuse cerebral and cerebellar
volume loss; brain MRI at the time of the behavioral
assessment (Figure 1) showed mild atrophy, predomi-
nantly affecting left frontal and perisylvian regions. Periph-
eral electrophysiological studies revealed no evidence of
anterior horn cell dysfunction or peripheral neuropathy.
Genomic screening identified a pathologic hexanucleotide
expansion in the C9ORF72 gene.
DC1
DC1 is a 63-year-old right-handed male retired plumber.
He presented with a 6-year history of progressive person-
ality change, initially with uncharacteristic aggressive out-
bursts and supervening social withdrawal, obsessionality,
behavioral rituals, and sweet tooth. Memory impairment
was another prominent early feature. No history of
delusions, hallucinations, or other perceptual disturbance
was present. The patient had a known family history of
early-onset frontotemporal dementia with autosomal
dominant inheritance. His general neurologic examina-
tion was normal. In particular, no features of motor neu-
ron disease were noted. Serial neuropsychological
assessments over a 6-year interval demonstrated progres-
sive impairment, particularly affecting naming and
Table 1 Demographic and neuropsychological
characteristics of patients and healthy controls
NT DC1 DC2 Healthy
controlsa
(n = 4)
Age (years) 67 63 74 67 (6.03)
Education (years) 15 12 16 15 (2)
General intellect
WASI VIQ 118 63 115 72 (3.4)
WASI PIQ 132 91 111 57 (2.6)
NART (/50) >75th <25th >90th 41 (4.8)
Episodic memory
RMT Words (/50) 25-
50th
<5th 5-10th 44 (5.2)
RMT Faces (/50) >95th <5th <5th 46 (6.1)
Executive function
D-KEFS Stroop word >50th >50th >50th 21 (3.5)
D-KEFS Stroop
Inhibition
>50th >50th >50th 53 (15.5)
Semantic processing
BPVS (/150) 146 103 138 149 (1.5)
Other skills
GNT (/30) >50th <1st <1st 27 (2.9)














VOSP >95th 25-50th >50th 19 (0.5)
CBI 52 203 46 n/a
Experimental
conditionsb
Self (/10) 10 10 10 9.5 (9-10)
Synchronous (/10) 3 7 5 6.5 (5-7)
Asynchronous (/10) 4 9 10 9.5 (9-10)
Percentile ranking scores of neuropsychological performance are shown. Raw
scores are listed where percentile scores are not available or applicable. BPVS,
British Picture Vocabulary Scale; CBI, Cambridge Behavioural Inventory total
score (across domains including mood, beliefs, challenging behaviors,
disinhibition, eating, sleep, stereotypies, motivation, and insight (Wedderbum
et al., 2008)); D-KEFS Stroop (word and inhibition), Delis-Kaplan Executive
Function System; DS, digit span; GNT, Graded Naming Test; n/a, not
applicable; NART, National Adult Reading Test; RMT, Recognition Memory Test;
Verbal Intelligence score; VOSP, Visual Object and Space Perception battery;
WASI PIQ, Wechsler Abbreviated Scale of Intelligence-Performance Intelligence
score; WASI VIQ, Wechsler Abbreviated Scale of Intelligence, aMean (standard
deviation) values shown, except for experimental conditions, in which mean
(range) values shown. bSee text for explanation.
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executive functions; DC1’s general neuropsychological
data at the time of the experimental assessment are sum-
marized in Table 1. DC1 fulfilled current consensus cri-
teria for a syndromic diagnosis of bvFTD [10].
Serial registered T1-weighted volumetric brain MRI
demonstrated progressive cerebral atrophy, most marked
in the anteromesial temporal lobes, which were relatively
symmetrically affected (Figure 1). Genomic screening
demonstrated a c.1216C>T (p.Arg406Trp) mutation of
the microtubule-associated protein tau (MAPT) gene.
DC2
DC2 is a 76-year-old left-handed male retired professor of
English literature. He presented with an 11-year history of
progressive prosopagnosia and personality change with
social disinhibition and obsessionality. No history of delu-
sions, hallucinations, or other perceptual disturbance was
noted, with no known family history of dementia. The
general neurologic examination was normal. Serial neu-
ropsychological assessments over a 6-year interval demon-
strated a largely stable profile with prominent anomia and
recognition memory dysfunction; DC2’s general neuropsy-
chological data at the time of the experimental assessment
are summarized in Table 1. DC2 fulfilled current consen-
sus criteria for a syndromic diagnosis of bvFTD [10].
Serial registered T1-weighted volumetric brain MRI
demonstrated progressive cerebral volume loss involving
Figure 1 Representative coronal T1-weighted MR brain sections for the patient with C9ORF72-associated frontotemporal dementia
(NT) and for patients with non-C9ORF72-associated frontotemporal dementia (DC1 and DC2). Sections have been selected to capture the
anterior frontal lobes and temporal poles (top row), anterior perisylvian regions and medial temporal lobes (middle row), and posterior parietal
lobes and cerebellum (bottom row). Scans were acquired at the time of the behavioral assessment. The left hemisphere is shown on the right in
all sections.
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the anterior temporal and frontal lobes, more marked
on the right (Figure 1). Genomic screening excluded a
C9OR72 mutation.
Healthy control subjects
Four healthy right-handed male control subjects (mean
age, 67 years; range, 58 to 72 years; see Table 1) matched
to NT for age (t5 = 0.04; P > 0.05) and with similar educa-
tional and social backgrounds but no history of neurologic
or psychiatric illness also were assessed.
This study was approved by the local research ethics
committee under Declaration of Helsinki guidelines. All
subjects gave informed consent to participate, and pro-
vided consent to publish.
Experimental assessment
The experimental set-up is schematized in Figure 2. A
paintbrush (14.5 × 1 cm, 1"25 was suspended by using a
cross-clamp from a rod positioned between two table-
mounted retort stands, such that the rod (and the attached
paintbrush) could be rotated freely by manipulating a han-
dle attached to one end. The subject was positioned with
his dominant hand resting palm-down on the table
between the retort stands, and the apparatus was adjusted
so that the paintbrush lightly tracked across the skin of
the hand when the handle was rotated by the subject,
using his nondominant hand. During the experiment, the
paintbrush was randomly moved along the suspending rod
from trial to trial, such that the brush either would contact
the subject’s hand ("self” condition) or would not contact
the subject’s hand ("non-self” trials); on “other” trials, the
experimenter delivered the tactile stimulus by using an
identical paintbrush, either in time with the subject’s own
action (synchronous condition) or with a short delay
(around 1 second; asynchronous condition). The retort-
mounted paintbrush was shifted by the experimenter
before every trial (whether self or non-self) to minimize
any extraneous cues from sound or the absolute position
of the brush. The subject was blindfolded and instructed
to rotate the handle 3 times in every trial: the task on each
trial was to decide whether the brush stimulus was gener-
ated by the subject’s own action or by that of the experi-
menter. It was established before commencing the
experiment that subjects were able reliably to detect the
sensory stimulus delivered by the brush. Thirty experi-
mental trials were administered, comprising 10 self, 10
non-self synchronous, and 10 non-self asynchronous trials
in randomized order. Subject responses were recorded and
stored for offline analysis. No time limit was imposed, and
no feedback about performance was given during the test.
Patients’ performance was compared with that of
healthy control subjects by using the Crawford and
Howell modified one-tailed t test for significant differ-
ences in single-case studies [11] and with a significance
threshold of P < 0.05.
Results
Results on the experimental behavioral test are summar-
ized in Table 1. Compared with healthy controls, NT
exhibited a significant deficit of self-other differentiation
over all experimental conditions (t5 = -3.48; P < 0.021).
Analyses of the three experimental conditions separately
revealed that NT’s performance was flawless for attribu-
tion of self-generated actions, whereas he performed sig-
nificantly worse than healthy controls for attribution of
both synchronous, non-self-generated actions (t5 = -4.05;
P < 0.008) and asynchronous, non-self-generated actions
(t5 = -5.5, P < 0.001). NT’s errors were therefore entirely
overattributions of the experimenter’s actions on non-self
trials as self-generated responses. Like NT, patients DC1
and DC2 correctly attributed all self-generated actions.
However, in contrast to NT, DC1 and DC2 showed no
significant differences in performance relative to healthy
controls on either of the non-self conditions (DC1: over-
all t5 = 0.12, synchronous t5 = 0.45, asynchronous t5 =
-0.78; DC2: overall t5 = -0.36, synchronous t5 = -1.34,
Figure 2 Schematic diagram of the experimental setup in the “self” and “other” action task conditions. See text for further explanation.
Downey et al. Alzheimer?’?s Research & Therapy 2012, 4:42
http://alzres.com/content/4/5/42
Page 4 of 6
asynchronous t5 = 0.78; all P > 0.05), and each patient’s
performance fell within the control range for every
condition.
Discussion
It is evident from the range of scores (Table 1) that
healthy controls and patients alike performed generally
rather poorly on the synchronous non-self condition;
performance differences were exposed largely in the
asynchronous condition. This pattern of results suggests
that the experimenter was able to control accurately the
degree to which the external stimulus simulated (or did
not simulate) the effect of a self-generated action.
Conclusions
Here we have shown that differentiation of the effects of
one’s own versus others’ actions may become impaired
in frontotemporal dementia associated with the
C9ORF72 expansion. Indeed, the deficit of self-other dif-
ferentiation appeared disproportionate to NT’s otherwise
relatively mild cognitive phenotype. As this patient’s
cognitive evolution was otherwise so indolent, we
hypothesize that impaired self-other differentiation may
be a key feature in the development of the complex
behavioral disturbances that accompany the C9ORF72
expansion, or may to lead the development of more-
typical cognitive deficits. The specificity of this finding
for C9ORF72-associated frontotemporal dementia
remains to be resolved. However, the present data sug-
gest that the ability to distinguish one’s own from
others’ actions is not comparably affected in other forms
of frontotemporal dementia (including MAPT-associated
disease); nor does it appear to be simply a consequence
of more severe disease, as DC1 and DC2 were both sub-
stantially more cognitively impaired than was NT.
Together, these findings raise the possibility that
impaired self-other differentiation is a behavioral signal
of C9ORF72 mutations. It is of interest that NT tended
to “overattribute” others’ actions to his own agency. A
similar overattribution bias to self for actions of ambigu-
ous origin has been reported both in healthy individuals
[12,13] and in schizophrenia [14]. Both healthy controls
and the two patients without the C9ORF72 expansion
here made self-overattribution errors in the synchronous
non-self condition, but (unlike NT) were able to use the
increased temporal delay in the non-self asynchronous
condition to identify the external origin of the action.
Although the overattribution to self of external actions
may seem somewhat paradoxic in a condition such as
schizophrenia with delusions of external control, it has
been argued [6] that such a deficit might lead to an
impaired ability to model one’s own versus others’
actions and an abnormal sense of invasion by external
forces masquerading as oneself.
Previous theoretic accounts of the neurobiologic basis
for sense of agency [9,15] have accorded the cerebellum a
key role as a comparator of efferent and afferent motor
commands. However, the interpretation of agency is likely
to engage a distributed brain network also including thala-
mus and posterior parietal cortex for transmission and
integration of the sensory consequences of actions and
prefrontal and cingulate cortex for cognitive appraisal of
integrated percepts [16]. Impaired ability to distinguish the
effects of one’s own from others’ actions might therefore
potentially result from impaired prediction coding in the
cerebellum or defective integration of sensory percepts by
the thalamus or the parietal or prefrontal cortex [5,7,17].
The elements of this distributed network have been impli-
cated in neuroimaging [1,18] and neuropathologic
[4,18,19] studies of patients with C9ORF72 expansions.
Although neuroanatomic correlation was not possible
here, we hypothesize that dysfunction of the previously
delineated cortico-thalamo-cerebellar network may have
underpinned the behavioral deficit of self-other differentia-
tion exhibited by NT [5,7,9]. Although impaired self-other
action attribution has not, to our knowledge, been pro-
posed previously as a general mechanism of behavioral
decline in frontotemporal dementia, complex behavioral
phenotypes remain poorly characterized in pathophysiolo-
gic terms. It may be that a range of more basic deficits is
expressed in broadly similar behavioral phenotypes, within
which certain features (for example, early prominent neu-
ropsychiatric symptoms) may give a more-specific clue to
the key pathophysiologic mechanism at work with particu-
lar mutations. We propose that impaired self-other differ-
entiation in patients with C9ORF72 mutations may index
a generic mechanism of defective own-action modeling
and representation that may be somewhat analogous to
the deficit proposed previously in patients with schizo-
phrenia (6). Such a pathophysiologic mechanism could
potentially be expressed in a range of clinical neuropsy-
chiatric phenomena.
We present this single-case analysis with a number of
caveats and suggestions for future work. Foremost among
these, the findings require replication in a cohort of
patients with the C9ORF72 expansion, with both clinical
and neuroanatomic correlation. This patient did not exhi-
bit clinically overt psychotic symptoms (delusions, halluci-
nations, or other perceptual disturbances); it would be
particularly pertinent to test our hypothesis in a group of
patients who do exhibit such symptoms (for example, delu-
sions). The proposed role of the putative cortico-thalamo-
cerebellar network could be directly assessed in a structural
or functional brain-imaging paradigm. The use of other
tasks designed to explore self-other differentiation in this
population would further corroborate the present findings.
The specificity of the deficit for C9ORF72-associated fron-
totemporal dementia requires further corroboration
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through comparison with larger cohorts of patients repre-
senting other forms of genetic and sporadic frontotemporal
dementia. In addition, within the C9ORF72 expansion
group, a need exists to establish the time course of devel-
opment of the deficit in a longitudinal analysis. If our con-
jecture is correct, impaired self-other differentiation might
manifest as an early feature, possibly even presymptomati-
cally. The paradigm we propose is relatively straightforward
and could be adapted to group longitudinal applications.
We hope that our preliminary observation stimulates
further hypothesis-led work directed to establishing the
pathophysiologic basis of the complex behavioral disorders
that characterize this newly discovered entity.
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